REGISTERED NUMBER: 14342360 (England and Wales)

Unaudited Financial Statements for the Year Ended 30 September 2026

for

Pharma Design Limited

Page

Company Information

1

Balance Sheet

2

DIRECTOR:

S Cavani Ruini

REGISTERED OFFICE:

Mansion House

Manchester Road

Altrincham

Cheshire

WA14 4RW

REGISTERED NUMBER:

14342360 (England and Wales)

CURRENT ASSETS

617,570

536,189

CREDITORS

Amounts falling due within one year

(56,387

)

(107,341

)

NET CURRENT ASSETS

561,183

428,848

TOTAL ASSETS LESS CURRENT LIABILITIES

561,183

428,848

CAPITAL AND RESERVES

561,183

428,848

NOTES TO THE FINANCIAL STATEMENTS

1.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2025 - 1 ) .

2.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 September 2026 and 30 September 2025:

30.9.26

30.9.25

£

£

S Cavani Ruini

Balance outstanding at start of year

320,645

142,738

Amounts advanced

138,959

177,907

Amounts repaid

-

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

459,604

320,645

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 15 October 2026 and were signed by:

S Cavani Ruini - Director